Updates are available Correction dated 2024-12-20

Article History

Accepted: 18 July 2024

First Online: 20 August 2024

Change Date: 2 January 2025

Change Type: Update

Change Details: The original online version of this article was revised to include the missing graphical abstract file.

Change Date: 20 December 2024

Change Type: Correction

Change Details: A Correction to this paper has been published:

Change Details: https://doi.org/10.1007/s40268-024-00494-2

Declarations

:

: MTR, SL, GK, GDM, JD, AS, AS, PAH, LHP, KM, MS, and MEM contributed to data selection and interpretation, and were involved in the review design. All authors contributed to the development of the manuscript, reviewed and commented on each draft, and approved the final draft.

: Not applicable.

: Not applicable.

: All authors have consented to the publication of this review.

: Mark T. Reding has received grants and research support from Bayer and BioMarin; honoraria and consultation fees from Bayer, CSL Behring, Novo Nordisk, Sanofi Genzyme and Takeda; and participates in a company-sponsored speakers bureau for Bayer, CSL Behring, Sanofi Genzyme, and Takeda. Shadan Lalezari has participated in advisory boards for Bayer; and has received honoraria or consultation fees from Bayer, Teva Pharmaceuticals, Takeda, PI Healthcare, Roche, and Pfizer. Gili Kenet has no disclosures to declare. Giovanni Di Minno has participated in speakers bureaus for Bayer, CSL Behring, Novo Nordisk, Pfizer, Sobi and Takeda; and has received consultancy or speakers fees from Bayer, Novo Nordisk, Pfizer, Sanofi Aventis, and Sobi. Jonathan Ducore has received consultancy fees from Bayer and HEMA Biologics and has participated in speakers bureaus for Bayer. Alexander Solms is an employee and shareholder of Bayer AG. Anita Shah is an employee of Bayer and owns Bayer stocks. Pål André Holme has received grant/research support, paid to his institution, from Bayer, Octapharma, Pfizer, Shire, and Sobi, and is a consultant for Bayer, Biomarin, CSL, Novo Nordisk, Octapharma, Pfizer, Roche, Shire, and Sobi. Lone H. Poulson has received grant/research support from Pfizer, and congress support from Bayer, Novo Nordisk, Octapharma, Pfizer, and Sobi. Karina Meijer has no disclosures to declare. Mindy Simpson has received institutional research grants from Bayer, Bioverativ/Sanofi, Daichii-Sankyo, Octapharma, Novo Nordisk, Baxalta (Shire, Takeda), and Roche (Genentech), and has received honoraria and consultation fees from Bayer, CSL Behring, Octapharma, Novo Nordisk, Roche, and Takeda/Shire. Maria Elisa Mancuso has received honoraria and consultation fees from Bayer, Bioverativ, Catalyst, CSL Behring, Grifols, Kedrion, Novo Nordisk, Octapharma, Pfizer, Roche, BioMarin, Shire/Takeda and Sobi, and participates in a company-sponsored speakers bureau for Bayer, CSL Behring, Grifols, Kedrion, Novo Nordisk, Octapharma, Pfizer, Roche, BioMarin, Shire/Takeda and Sobi.

: Not applicable.